Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604861 · ClinicalTrials.gov registry record
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
A clinical trial of Opioid Use Disorder and Opioid-Related Disorders, sponsored by Indivior.
- Completed
- Registry status
- 534
- Enrollment target
- 20
- Study locations
NCT03604861 is a study of Opioid Use Disorder and Opioid-Related Disorders that has completed, run by Indivior. The registered enrollment target is 534 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT03604861, a study of Opioid Use Disorder and Opioid-Related Disorders, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- 534 participants
- Enrollment target
- 20
- Study locations
Study Summary
The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of participants from studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003). The RECOVER study will characterize OUD subjects' recovery process as they transition from the controlled clinical trial environment to the real world setting.
Conditions Studied
Interventions
- OTHER Not applicable - no defined intervention
Study Locations (20)
Florida
- Amit Vijapura - Jacksonville
- Meridien Research - Lakeland
- Try Research - Maitland
- Innovative Clinical Research - Miami
- Scientific Clinical Research - Miami
- Research Centers of America - Oakland Park
California
- Behavioral Research Specialists - Glendale
- Collaborative Neuroscience Networks, Inc. - Long Beach
- Synergy Research Center - National City
- North County Clinical Research - Oceanside
- Artemis Institute for Clinical Research - San Diego
Alabama
- Winston Technology Research LLC - Haleyville
- Boyett Health Services - Hamilton
Louisiana
- Louisiana Research Associates - New Orleans
- Louisiana Clinical Research - Shreveport
Massachusetts
- Stanley Street Treatment and Resources - Fall River
- Adams Clinical Trials - Watertown
Arkansas
- Woodland International Research Group - Little Rock
Mississippi
- Precise Research Centers, Inc. - Flowood
Missouri
- St. Louis Clinical Trials - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03604861
The ClinicalTrials.gov registry entry for NCT03604861 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 534 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Not applicable - no defined intervention is the first listed.
NCT03604861 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT03604861 about?
NCT03604861 is a clinical study titled "An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery". The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of particip...
What is the current status of trial NCT03604861?
This trial is currently completed. The enrollment target is 534 participants. The study started on 2015-08. Estimated completion is 2019-03.
What conditions does trial NCT03604861 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid-Related Disorders.
What interventions are being tested in trial NCT03604861?
The interventions under investigation include: Not applicable - no defined intervention (OTHER).
Who is sponsoring clinical trial NCT03604861?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03604861 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.